10078 participants
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-12-21
- Start Date:
- 2020-06-16
- Completion:
- 2022-01-21
Conditions
- COVID-19
Interventions
- DRUG